Physician profile
Robert S Pushkin
NPI 1538359955
$1,099.05
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $658 · 2020: $185 · 2021: $202 · 2022: $27.22 · 2023: $25.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $25.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $25.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $246.76 | 2019-2022 | |
| Shire North American Group INC | $131.46 | 2019 | |
| Corcept Therapeutics | $78.73 | 2019 | |
| Therapeuticsmd, INC. | $77.97 | 2019-2021 | |
| Abbott Laboratories | $65.53 | 2019-2020 | |
| Mannkind Corporation | $59.91 | 2019 | |
| Valeritas, INC. | $59.02 | 2019 | |
| Allergan, INC. | $56.82 | 2019-2020 | |
| Minerva Surgical, INC | $56.33 | 2021 | |
| Hologic Sales and Service, LLC | $48.99 | 2019-2023 | Aptima |
| Novo Nordisk INC | $43.99 | 2019-2020 | |
| Lilly USA, LLC | $40.17 | 2019 | |
| Sanofi-Aventis U.S. LLC | $33.68 | 2019 | |
| Senseonics, Incorporated | $20.00 | 2020 | |
| Exeltis, USA INC. | $17.64 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $16.00 | 2020 | |
| Amag Pharmaceuticals, INC. | $15.91 | 2019 | |
| Evofem Biosciences, INC. | $15.52 | 2021 | |
| Avion Pharmaceuticals | $14.62 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Pushkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.